Stocks and Investing Stocks and Investing
Fri, January 27, 2023
[ 12:00 AM ] - WOPRAI
Tien-Tsin Huang Maintained (V) at Buy with Increased Target to $265 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
James Faucette Maintained (V) at Buy with Increased Target to $288 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Ashwin Shirvaikar Maintained (V) at Strong Buy and Held Target at $265 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Rayna Kumar Maintained (V) at Strong Buy with Increased Target to $293 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Keith Horowitz Maintained (USB) at Hold with Increased Target to $54 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Peter Winter Maintained (USB) at Hold with Increased Target to $50 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Ken Newman Maintained (URI) at Buy with Increased Target to $515 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Adam Seiden Maintained (URI) at Sell with Increased Target to $350 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Jerry Revich Maintained (URI) at Strong Buy with Increased Target to $436 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Stanley Elliott Maintained (URI) at Strong Buy with Increased Target to $505 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Nicole Deblase Maintained (URI) at Hold with Increased Target to $399 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Ivan Feinseth Reiterated (WEN) at Strong Buy and Held Target at $29 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Jared Shaw Maintained (WBS) at Hold with Increased Target to $60 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
David Chiaverini Maintained (WBS) at Hold with Increased Target to $55 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Cory Carpenter Maintained (VZIO) at Buy with Decreased Target to $13 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Kenneth Worthington Maintained (VIRT) at Buy with Decreased Target to $22 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Christopher Allen Maintained (VIRT) at Hold with Decreased Target to $21 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Theresa Chen Maintained (VLO) at Buy with Increased Target to $159 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Ryan Todd Maintained (VLO) at Buy with Increased Target to $173 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
John Royall Maintained (VLO) at Buy with Increased Target to $160 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Steve Moss Maintained (VLY) at Strong Buy with Decreased Target to $13 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Manan Gosalia Maintained (VLY) at Hold with Decreased Target to $13 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Glen Santangelo Upgraded (VTRS) to Strong Buy and Increased Target to $15 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Jeff Jones Maintained (VTYX) at Buy with Increased Target to $60 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Scott Stember Maintained (WGO) at Hold with Increased Target to $61 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
James Fotheringham Maintained (WRLD) at Sell with Decreased Target to $32 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Atif Malik Maintained (WOLF) at Strong Buy with Decreased Target to $95 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Bruno Amorim Maintained (YPF) at Strong Sell with Increased Target to $5.8 on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Michael Ulz Downgraded (YMAB) to Sell on, Jan 27th, 2023
[ 12:00 AM ] - WOPRAI
Michael Ulz Maintained (XLO) at Buy with Decreased Target to $10 on, Jan 27th, 2023

Michael Ulz Maintained (XLO) at Buy with Decreased Target to $10 on, Jan 27th, 2023


Published on 2024-10-28 01:08:55 - WOPRAI, Michael Ulz
  Print publication without navigation


Michael Ulz of Morgan Stanley, Maintained "Xilio Therapeutics, Inc." (XLO) at Buy with Decreased Target from $20 to $10 on, Jan 27th, 2023.

Michael has made no other calls on XLO in the last 4 months.



There are 2 other peers that have a rating on XLO. Out of the 2 peers that are also analyzing XLO, 0 agree with Michael's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Michael

  • Matthew Barcus of "Chardan Capital" Initiated at Strong Buy and Held Target at $7 on, Wednesday, December 21st, 2022
  • Dane Leone of "Raymond James" Maintained at Buy with Decreased Target to $13 on, Thursday, November 10th, 2022
Contributing Sources